Evidence for cyclic diguanylate as a vaccine adjuvant with novel immunostimulatory activities.
暂无分享,去创建一个
D. Zaller | K. Vora | J. Demartino | T. Fu | D. Freed | Gail Forrest | G. Porter | Joseph F. Leone | Peter M. Gray | Zhiqiang Guo | T. Wisniewski | P. M. Gray | J. DeMartino
[1] Yoshihiro Hayakawa,et al. STING is a direct innate immune sensor of cyclic-di-GMP , 2011, Nature.
[2] R. Cox,et al. Intranasal c-di-GMP-adjuvanted plant-derived H5 influenza vaccine induces multifunctional Th1 CD4+ cells and strong mucosal and systemic antibody responses in mice. , 2011, Vaccine.
[3] E. Montomoli,et al. Current adjuvants and new perspectives in vaccine formulation , 2011, Expert review of vaccines.
[4] V. Schijns,et al. Trends in vaccine adjuvants , 2011, Expert review of vaccines.
[5] N. Garçon,et al. Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems , 2011, Expert review of vaccines.
[6] H. Sahly. MF59™ as a vaccine adjuvant: a review of safety and immunogenicity , 2010 .
[7] H. Qiu,et al. 3',5'-Cyclic diguanylic acid elicits mucosal immunity against bacterial infection. , 2009, Biochemical and biophysical research communications.
[8] K. Ishii,et al. A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP , 2009, The Journal of experimental medicine.
[9] Yifan Ma,et al. Toll-Like Receptor 3 Ligand and Retinoic Acid Enhance Germinal Center Formation and Increase the Tetanus Toxoid Vaccine Response , 2009, Clinical and Vaccine Immunology.
[10] D. Kaufman,et al. Translational Mini‐Review Series on Vaccines for HIV: T lymphocyte trafficking and vaccine‐elicited mucosal immunity , 2009, Clinical and experimental immunology.
[11] D. Karaolis,et al. c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection. , 2009, Vaccine.
[12] Barbara Rehermann,et al. Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. , 2009, The Journal of clinical investigation.
[13] D. Zaller,et al. Genetic ablation or pharmacological blockade of dipeptidyl peptidase IV does not impact T cell-dependent immune responses , 2009, BMC Immunology.
[14] P. Marrack,et al. Towards an understanding of the adjuvant action of aluminium , 2009, Nature Reviews Immunology.
[15] Xiaoyu Hu,et al. Regulation of interferon and Toll‐like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms , 2008, Immunological reviews.
[16] J. McCullers,et al. c-di-GMP is an effective immunomodulator and vaccine adjuvant against pneumococcal infection. , 2008, Vaccine.
[17] S. Plotkin,et al. Vaccines: correlates of vaccine-induced immunity. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] Henk C. Hoogsteden,et al. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells , 2008, The Journal of experimental medicine.
[19] A. Camilli,et al. Roles of cyclic diguanylate in the regulation of bacterial pathogenesis. , 2007, Annual review of microbiology.
[20] T. Standiford,et al. Cyclic Di-GMP Stimulates Protective Innate Immunity in Bacterial Pneumonia , 2007, Infection and Immunity.
[21] A. Jegerlehner,et al. TLR9 Signaling in B Cells Determines Class Switch Recombination to IgG2a , 2007, The Journal of Immunology.
[22] J. Schroeder,et al. Bacterial c-di-GMP Is an Immunostimulatory Molecule1 , 2007, The Journal of Immunology.
[23] T. Ebensen,et al. The bacterial second messenger cyclic diGMP exhibits potent adjuvant properties. , 2007, Vaccine.
[24] P. Sly,et al. CpG methylation patterns in the IFNγ promoter in naive T cells: Variations during Th1 and Th2 differentiation and between atopics and non‐atopics , 2006, Pediatric Allergy and Immunology.
[25] A. Krieg,et al. Therapeutic potential of Toll-like receptor 9 activation , 2006, Nature Reviews Drug Discovery.
[26] J. J. Zhang,et al. Stat1-Dependent Synergistic Activation of T-bet for IgG2a Production during Early Stage of B Cell Activation1 , 2005, The Journal of Immunology.
[27] S. Holland,et al. Defects in the interferon‐γ and interleukin‐12 pathways , 2005, Immunological reviews.
[28] Roger A. Jones,et al. c-di-GMP displays a monovalent metal ion-dependent polymorphism. , 2004, Journal of the American Chemical Society.
[29] N. Petrovsky,et al. Vaccine adjuvants: Current state and future trends , 2004, Immunology and cell biology.
[30] C. Walker,et al. Cell-mediated immunity and the outcome of hepatitis C virus infection. , 2004, Annual review of microbiology.
[31] P. Sly,et al. Functional Maturation of CD4+CD25+CTLA4+CD45RA+ T Regulatory Cells in Human Neonatal T Cell Responses to Environmental Antigens/Allergens1 , 2004, The Journal of Immunology.
[32] C. Van Lint,et al. A Defect in Nucleosome Remodeling Prevents IL-12(p35) Gene Transcription in Neonatal Dendritic Cells , 2004, The Journal of experimental medicine.
[33] Qing He,et al. Antibody regulation of T-cell immunity: implications for vaccine strategies against intracellular pathogens , 2004, Expert review of vaccines.
[34] Sambasiva P Rao,et al. Cutting Edge: Germinal Centers Formed in the Absence of B Cell-Activating Factor Belonging to the TNF Family Exhibit Impaired Maturation and Function , 2003, The Journal of Immunology.
[35] C. Bode,et al. CpG DNA as a vaccine adjuvant , 2003, Expert review of vaccines.
[36] F. Eko,et al. Contemporary approaches to designing and evaluating vaccines against Chlamydia , 2003, Expert review of vaccines.
[37] M. Starnbach,et al. T cell responses to Chlamydia trachomatis. , 2002, Current opinion in microbiology.
[38] J. Vekemans,et al. Deficient IL-12(p35) Gene Expression by Dendritic Cells Derived from Neonatal Monocytes1 , 2001, The Journal of Immunology.
[39] S. Dorman,et al. Interferon-γ and interleukin-12 pathway defects and human disease , 2000 .
[40] T. Manser,et al. Amplified follicular immune complex deposition in mice lacking the Fc receptor gamma-chain does not alter maturation of the B cell response. , 1997, Journal of immunology.
[41] P. Matzinger,et al. Neonatal Tolerance Revisited: Turning on Newborn T Cells with Dendritic Cells , 1996, Science.
[42] J. H. Boom,et al. Regulation of cellulose synthesis in Acetobacter xylinum by cyclic diguanylic acid , 1987, Nature.
[43] M. Struthers,et al. Synthesis and immunological activities of novel agonists of toll-like receptor 9. , 2010, Cellular immunology.
[44] R. Coffman,et al. Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.